In terms of investigating new therapeutic strategies for ALS, Riehm et al. studied the gain in function of mutant SOD1, forming small soluble oligomers that acquire membrane toxicity, damaging membranes and “toxic channels” (Riehm et al. 2018). Here, SOD1 is linked to amyotrophic lateral sclerosis.